Dihydrotachysterol
Not to be confused with Dihydrotestosterone.
Systematic (IUPAC) name | |
---|---|
(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a682335 |
Identifiers | |
CAS Number | 67-96-9 |
ATC code | A11CC02 |
PubChem | CID 5311071 |
DrugBank | DB01070 |
ChemSpider | 4470607 |
UNII | R5LM3H112R |
KEGG | D00299 |
ChEBI | CHEBI:4591 |
Chemical data | |
Formula | C28H46O |
Molar mass | 398.664 g/mol |
| |
| |
(verify) |
Dihydrotachysterol (DHT) is a synthetic vitamin D analog activated in the liver that does not require renal hydroxylation like vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on mineralization of bone salts than does vitamin D.[1]
References
- ↑ R. Gagnon, G. W. Ogden, G. Just, M. Kaye (1974). "Comparison of Dihydrotachysterol and 5,6-trans Vitamin D3 on Intestinal Calcium Absorption in Patients with Chronic Renal Failure". Canadian Journal of Physiology and Pharmacology 52 (2): 272–274. doi:10.1139/y74-037. PMID 4365509.
|
This article is issued from Wikipedia - version of the Saturday, August 22, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.